(Q60050876)

English

Improved high-performance liquid chromatographic analysis with double detection system for l-DOPA, its metabolites and carbidopa in plasma of Parkinsonian patients under l-DOPA therapy

scientific article published on 01 December 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Improved high-performance liquid chromatographic analysis with double detection system for L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients under L-dopa therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Parkinson's disease

1 reference

based on heuristic

inferred from title

(S)-(−)-carbidopa monohydrate

1 reference

based on heuristic

inferred from title

Fabrizio Stocchi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

P Betto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

G Ricciarello

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

M Giambenedetti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

C Lucarelli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

S Ruggeri

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

language of work or name

0 references

publication date

1 December 1988

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Journal of Chromatography

0 references

459

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

341-349

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

3-O-methyldopa blocks dopa metabolism in rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with parkinson's disease before and during treatment with L-dOPA

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Simultaneous determination of carbidopa, levodopa and 3,4-dihydroxyphenyl-acetic acid using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

High-performance liquid chromatography with amperometric detection of plasma L-3,4-dihydroxyphenylalanine in Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Simultaneous determination of L-dopa and 3-O-methyldopa in human serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Simultaneous assay of 3,4-dihydroxyphenylalanine, catecholamines and O-methylated metabolites in human plasma using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Determination of m- and p-O-methylated products of L-3,4-dihydroxyphenylalanine using high-performance liquid chromatography and electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Simultaneous determination of levodopa, carbidopa, 3-O-methyldopa and dopamine in plasma using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Simultaneous determination of levodopa, its metabolites and carbidopa in clinical samples

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Plasma catecholamines in hypertension and pheochromocytoma determined using ion-pair reversed-phase chromatography with amperometric detection: investigation of the separation mechanism and clinical methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

Automated measurement of catecholamines in urine, plasma and tissue homogenates by high-performance liquid chromatography with fluorometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

3-O-methyldopa and the response to levodopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2982046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9673(01)82046-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3243910%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60050876&oldid=1746959793"